MedTrace Logo

Body Weight-Supported and Virtual Reality Gait Training in Stroke Patients

NCT07550270 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-24

No results posted yet for this study

Summary

The aim of this study is to compare the effects of body weight-supported gait training that includes virtual reality-assisted dual-task applications with body weight-supported forward and backward gait training on functional capacity, gait parameters (such as step length, gait speed, and balance), cognitive functions and psychological status in patients with stroke. The findings of this study are expected to contribute to the development of more effective rehabilitation strategies for improving mobility in patients with stroke

Conditions

  • Stroke
  • Walking Impairment
  • Balance
  • Gait Training

Interventions

OTHER

Virtual Reality-Assisted Gait Training

Body weight-supported virtual reality-assisted forward gait training with 30% body weight support, applied five days per week for six weeks.

OTHER

Backward Gait Training

Body weight-supported backward gait training with 30% body weight support, applied five days per week for six weeks.

OTHER

Forward Gait Training

Body weight-supported forward gait training with 30% body weight support, applied five days per week for six weeks.

Sponsors & Collaborators

  • Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

    lead OTHER

Principal Investigators

  • Tuğba ATAN, Associate Professor, MD · Gaziler Physical Medicine and Rehabilitation Training And Research Hospital

  • Bilge YILMAZ, Professor, MD · Gaziler Physical Medicine and Rehabilitation Training And Research Hospital

  • Eda GÜRÇAY, Professor, MD · Gaziler Physical Medicine and Rehabilitation Training And Research Hospital

  • Engin KOYUNCU, Professor, MD · Gaziler Physical Medicine and Rehabilitation Training And Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-26
Primary Completion
2026-11-30
Completion
2026-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07550270 on ClinicalTrials.gov